Bispecifics Update: Your Guide to Thriving with Multiple Myeloma

Bispecifics Update
Multiple Myeloma Expert Tips and Insights - Now ON DEMAND

Are you navigating life with multiple myeloma and seeking ways to live better while managing your condition?
 

Watch an empowering session where myeloma expert Dr. Carl Ola Landgren, University of Miami Sylvester Comprehensive Cancer Center, shares actionable insights on the latest treatments, effective side effect management, and innovative therapies such as bispecifics and CAR T-cell therapy. Gain the knowledge you need to thrive with multiple myeloma and take charge of your journey.

  • Select an “On Demand” session to watch right now.
  • Select a “Replay” session to have a link sent to you.
Why Attend?
  • Stay Updated: Learn about the newest treatments like CAR T-cell therapy and bispecific antibodies.
  • Manage Side Effects: Discover effective strategies for managing treatment side effects to improve your quality of life.
  • Thrive Daily: Get expert tips for living well and staying active while managing multiple myeloma.
  • Personalized Insights: Understand how to tailor your treatment journey with the latest medical advancements and expert advice.

Program Speakers

Dr. Carl Ola Landgren

Hematologist-Oncologist
Sylvester Comprehensive Cancer Center

University of Miami

Kenny Kapps

Multiple Myeloma Survivor
Patient Advocate

Thank you to The Leukemia & Lymphoma Society for their partnership. The Leukemia & Lymphoma Society is here for you with information about clinical trials, resources, and support.

Johnson and Johnson J&J logo

Thank you to Johnson & Johnson for its support of our patient education program! The Patient Story retains full editorial control over all content.

Your Guide to Thriving with Multiple Myeloma: Expert Tips and Insights
Hosted by The Patient Story
Join us for an empowering session where a leading expert shares actionable insights on the latest treatments, effective side effect management, and innovative therapies such as bispecifics and CAR-T cells.
Powered by
Powered by